DOXEPIN HCL
Zydus receives anti-hypertensive drug approvalZydus Cadila has received tentative approval from the US drug authorities for two anti-hypertensive drugs.- Zydus Cadila gets approval for Doxepin Hcl, to launch in 2020The estimated sales in 2012 as per IMS for Doxepin Hcl, which falls in the neuropsychiatry segment, was $15.5 million, as per company.
- Load More